Search Results
Aug 20, 2026, 08:10 ET West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective option to surgical tumor removal that is easily performed in a relatively short procedure.
More news about: IceCure Medical
Aug 20, 2026, 08:05 ET Maverix Medical Announces FDA 510(k) Clearance for the Narwhal™ Cryo System
MedicalMaverix Medical aims to improve and save lives by revolutionizing the diagnosis and treatment of lung cancer. We seek to bring cutting-edge technologies to lung cancer care, empowering clinicians to diagnose lung cancer earlier and treat patients more effectively.Media Contact:Will Kynes,
More news about: Maverix Medical
Aug 20, 2026, 07:45 ET Radiopaque, Polymer-Based Embolic Coil Tops 125 Implants, With Minimal Artifacts in CT, MRI Imaging
plugs, particles and liquid embolics) have their place in the market, says Richard Kovach, M.D., an interventional cardiologist at Deborah Heart and Lung Center in Browns Mills, N.J., coils are the primary and largest technology used in embolization procedures."This novel polymer-based coil has
More news about: Embolization, Inc.
Aug 20, 2026, 07:05 ET IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released Investigational Oncology Therapies
(FDA)'s 505(b)(2) regulatory pathway and believes the technology may have future applicability across additional solid tumor indications, including lung, brain, gastrointestinal, ovarian and testicular cancers.About IntraGel TherapeuticsIntraGel develops long-acting injectable therapies
More news about: IntraGel Therapeutics
Aug 20, 2026, 02:22 ET Akiram Therapeutics and ITM Sign Lutetium-177 Supply Agreement to Support Development of AKIR001 for the Treatment of Solid Tumors
NCT06639191) at Stockholm's Karolinska University Hospital in patients with irresectable or metastatic CD44v6-positive solid tumors, including lung, head and neck, thyroid, and gynecological cancers."At ITM, we remain committed to advancing and enabling the development of innovative radiopharmaceuticals
More news about: Akiram Therapeutics
Aug 19, 2026, 14:18 ET Vascarta Announces NIH Phase I clinical study of VAS-101 in sickle cell disease begins
investigator, Dr. Swee Lay Thein, Chief, Laboratory of Sickle Cell Genetics and Pathophysiology and Chief, Sickle Cell Branch, at NIH's National Heart, Lung and Blood Institute.
More news about: Vascarta Inc.
Aug 19, 2026, 10:31 ET Checkpoint Inhibitor Refractory Cancer Market Outlook is Predicted to Improve by 2036, Biopharma Companies Advance Novel Immuno-Oncology Candidates | DelveInsight
evaluated for the treatment of advanced solid tumors that have progressed despite prior checkpoint inhibitor therapy, with a primary focus on non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC). Clinical findings suggest that the combination may help overcome acquired resistance to PD-1 inhibitors
More news about: DelveInsight Business Research, LLP
Aug 19, 2026, 10:00 ET Pillar Biosciences, LC-SCRUM-Asia and LSI Medience Announce Liquid Biopsy Screening Collaboration in Lung Cancer
biopsy solution for analyzing cfDNA and cfRNA from patients with non-small cell lung cancer, while supporting the rapid turnaround needed for clinical research."Supporting blood-based genomic screening in lung cancerLiquid biopsy testing can enable genomic analysis from blood samples
More news about: Pillar Biosciences, Inc.
Aug 19, 2026, 09:14 ET XtalPi Holdings Announces 2026 Interim Results
clinical trial of SIGX1094 in combination with Innovent Biologics' approved KRAS-G12C inhibitor fulzerasib tablets for KRAS-G12C-mutated non-small cell lung cancer. SIGX2649, a pan-TEAD inhibitor being developed with Signet Therapeutics, has received IND clearance in both China and the United States. A Phase
More news about: XtalPi Holdings Limited
Aug 18, 2026, 21:00 ET Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit
documents subsequently submitted to the Hong Kong Stock Exchange.For more information, please contact:Investor Contacts: Donald LungE-mail: [email protected] Contacts:Ariel
More news about: Antengene Corporation Limited
Aug 18, 2026, 12:14 ET HelloNation Highlights the Importance of Radon Testing in Iowa Homes, Featuring Home Inspection Experts Logan Loftus & Nick Mullnix
indoor air quality.Radon exposure is a significant health concern. According to public health agencies, radon exposure is the leading cause of lung cancer among non-smokers. In Iowa homes, where radon levels may be elevated even without visible warning signs, testing provides clarity and allows
More news about: HelloNation
Aug 18, 2026, 08:45 ET Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms
More news about: Anixa Biosciences, Inc.
Aug 18, 2026, 08:04 ET Nationally Recognized Lung Cancer Researcher and ASCO Young Investigator Award Honoree, Tina Roy, MD, Joins the Physician Team at Virginia Cancer Specialists
cancer types, including lung, breast, gastrointestinal, and hematologic malignancies. In 2026, she received the Conquer Cancer Young Investigator Award from the American Society of Clinical Oncology for her research in HIV-associated lung cancer."Given my special interest in lung cancer, I'm particularly
More news about: Virginia Cancer Specialists
Aug 18, 2026, 08:00 ET Kedrion Biopharma Announces the Extension of a U.S. Agreement with Grifols to Support Long-Term and Continued Access to GAMMAKED®
compromise.Transfusion-related Acute Lung Injury (TRALI): Noncardiogenic pulmonary edema may occur in patients following treatment with IGIV products, including GAMMAKED. Monitor patients for pulmonary adverse reactions (transfusion-related acute lung injury [TRALI]).Volume Overload:
More news about: Kedrion Biopharma
Aug 18, 2026, 07:00 ET Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy
candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid), is being evaluated in two clinical trials as a treatment for NSCLC and SCLC. Each of Genprex's lung cancer clinical programs has received a Fast Track Designation from the FDA for the treatment of that patient population, and Genprex's SCLC program
More news about: Genprex, Inc.
Aug 18, 2026, 05:18 ET Fractal Wins US$17M+ Multi-Year AI Deal with a Fortune 500® U.S. Healthcare Organization
Qure.ai, a global healthcare AI leader focused on the rapid identification and management of tuberculosis, lung cancer, and stroke (or critical health conditions). Fractal's suite of businesses consists of Asper.ai (a
More news about: Fractal Analytics Limited
Aug 18, 2026, 05:03 ET Thousands Across America Lace Up to End Lung Cancer
launched our LUNG FORCE Initiative, we have raised more than $32 million for lifesaving lung cancer research, expanding our research commitment by 140%. Continued support will help us get closer to ending lung cancer and lung disease. Because when you can't breathe, nothing else matters."Lung cancer
More news about: American Lung Association
Aug 18, 2026, 05:01 ET Fractal Wins US$17M+ Multi-Year AI Deal with a Fortune 500® U.S. Healthcare Organization
Qure.ai, a global healthcare AI leader focused on the rapid identification and management of tuberculosis, lung cancer, and stroke (or critical health conditions). Fractal's suite of businesses consists of Asper.ai (a
More news about: Fractal Analytics Limited
Aug 18, 2026, 04:02 ET Bitmine Immersion Technologies (BMNR) Công Bố Lượng ETH Nắm Giữ Đạt 5,82 Triệu Token, Đưa Tổng Tài Sản Tiền Mã Hóa và Tiền Mặt Lên Mức 11,4 Tỷ USD
liên kết tại đây) cho tháng 7 năm 2026. Tiêu đề của Thông Điệp này là "ETH chính là liều thuốc giải cho Thung Lũng Kỳ Lạ của Sự Giàu Có."Vào đầu năm 2026, Bitmine đã ra mắt MAVAN (Made in American VAlidator Network) — nền tảng staking chuyên biệt dành cho
More news about: Bitmine Immersion Technologies, Inc.
Aug 18, 2026, 02:08 ET 台湾ウィークス2026、11月3～13日に開催、海外からの参加も拡大
Capital Hub）」をテーマに、世界各国の金融界のリーダーがこれまで以上に幅広く参加します。本イベントでは、台湾が持つテクノロジーと資本市場の強み、グローバルサプライチェーンにおける役割、アジア全域で高まるウェルスマネジメントサービスへの需要に焦点を当てます。FSC会長のDr. Jin-lung Pengは、「今年の『台湾ウィークス（Taiwan Weeks）』では、より幅広いテーマを扱い、より多様な参加者を迎え、国際的なつながりをさらに強化するとともに、台湾を世界に発信していきます」と述べました。 「世界市場が急速に変化する中、政府は台湾の金融・産業の変革を支援するため、市場開放措置を引き続き推進していきます。台湾ウィークス（Taiwan
More news about: Taiwan Stock Exchange Corporation
Aug 18, 2026, 01:41 ET Taiwan Weeks 2026 vindt plaats van 3 tot 13 november en verwelkomt meer internationale deelnemers
internationale banden verder versterken en Taiwan onder de aandacht brengen, met een breder scala aan onderwerpen en deelnemers", zei FSC-voorzitter dr. Jin-lung Peng. "Naarmate de wereldwijde markten zich snel ontwikkelen, zal de overheid doorgaan met het bevorderen van maatregelen om de markt verder open
More news about: Taiwan Stock Exchange Corporation
Aug 17, 2026, 16:59 ET Les Taiwan Weeks 2026 se tiendront du 3 au 13 novembre et bénéficieront d'une forte participation internationale
renforcer les liens internationaux et à mettre en valeur Taïwan, avec un éventail plus large de thèmes et de participants », a déclaré le Dr Jin-lung Peng, président de la FSC . « Face à l'évolution rapide des marchés mondiaux, le gouvernement continuera à mettre en œuvre des mesures d'ouverture
More news about: Taiwan Stock Exchange Corporation
Aug 17, 2026, 11:55 ET Taiwan Weeks 2026 für den 3. bis 13. November mit erweiterter internationaler Beteiligung geplant
internationalen Verbindungen weiter stärken und Taiwan mit einem breiteren Spektrum an Themen und Teilnehmenden präsentieren", sagte FSC-Vorsitzender Dr. Jin-lung Peng. „Angesichts der rasanten Entwicklung der globalen Märkte wird die Regierung weiterhin Maßnahmen zur Marktöffnung vorantreiben, um Taiwans
More news about: Taiwan Stock Exchange Corporation
Aug 17, 2026, 10:30 ET Cancer Diagnostics Market worth $44.92 billion by 2031 - Exclusive Report by MarketsandMarkets™
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121The increasing global burden of cancer, including breast, lung, colorectal, prostate, cervical, and hematologic cancers, is significantly expanding the adoption of cancer diagnostics. The rising prevalence of cancer
More news about: MarketsandMarkets
Aug 17, 2026, 10:07 ET Azra AI and 4DMedical Partner to Bring Enterprise-Wide Lung Health Intelligence to Health Systems
with 4DMedical's quantitative lung imaging analytics, giving physicians objective, measurable data to guide the next stage of care.Identify. Connect. Manage.The offering spans a broad set of lung health care pathways: COPD/emphysema, interstitial lung disease (ILD), pulmonary nodules,
More news about: Azra AI